What is the recommendation for using biomarkers to prevent heart failure?
The recommendation is for patients at risk of developing heart failure to undergo natriuretic peptide biomarker based screening followed by team-based care, including a cardiovascular specialist optimizing GDMT, in order to prevent the development of left ventricular dysfunction (systolic or diastolic) or heart failure. New data suggests that natriuretic peptide biomarker screening and early intervention may be effective in preventing heart failure. 